Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe site revision label changed from `v3.7.0` to `v3.7.1`.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision v3.7.0 was added to the study's history and the previous revision v3.6.6 was removed from the history, updating the version log.SummaryDifference0.1%

- Check53 days agoChange DetectedNew record revision v3.6.6 was added to the history, and the previous revision v3.6.5 was removed. This updates the study's version history.SummaryDifference0.1%

- Check67 days agoChange DetectedStudy Status and Recruitment Status were updated on 2026-08-14 to Suspended, with a sponsor note that ECR003 activities must halt and no additional subjects may be enrolled. This replaces the prior Active, not recruiting status recorded on 2025-10-20.SummaryDifference0.8%

- Check74 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the record history, signaling an update to the study record. The previous revision 'Revision: v3.6.4' was removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.